DAVA:NYSEEndava plc Analysis

Endava plc (DAVA) is trading at $4.34, well below its 20‑day SMA of $4.83 and 50‑day SMA of $5.36, with the 200‑day SMA still near $9.06, indicating a sustained bearish trend. The RSI of 34.7 suggests the stock is approaching oversold territory, yet the MACD histogram remains negative, reinforcing downside momentum. Technical indicators point to limited upside, with the nearest support at $4.21 and resistance at $5.57.
Fundamentally, the company posted a 5.9% revenue decline, negative operating and profit margins, and a troubling ROE of -0.48%, while carrying $249.4 M of debt against $68.5 M of cash. The DCF fair‑value estimate of $1.95 is far beneath the current price, highlighting a potential overvaluation despite a forward PE of 3.3 and a low price‑to‑book of 0.30. Analysts maintain a “buy” consensus, but the high beta (1.6), 30‑day volatility of over 60%, and decreasing volume amplify risk. Investors should weigh the bearish technical backdrop against the modest upside suggested by analyst targets, while remaining cautious of the company’s leverage and earnings weakness.